Donna Beer–Stolz

2.7k citations
28 papers · 2.2k indexed · h-index 21
Topics
Advanced Glycation End Products research (5 papers)Autophagy in Disease and Therapy (4 papers)Immunotherapy and Immune Responses (4 papers)

In The Last Decade

Donna Beer–Stolz

28 papers receiving 2.2k citations

Peers

Donna Beer–Stolz
Comparison fields: 5 of 110
  • Molecular Biology 869
  • Immunology 562
  • Surgery 540
  • Nutrition and Dietetics 356
  • Cancer Research 307
Replace Yan Huang with:
Yan Huang China
Chen Yang China
Lara Campana Italy
Toshiaki Nakano Japan
Evgenia Dobrinskikh United States
Ashish K. Sharma United States
Robert Zhong Canada
Yi Wen China
Qian Chen China
Peter Huebener Germany
Donna Beer–Stolz relative to Yan Huang China Yan Huang's profile →
Citations per field
00.5×9.9×
Yan Huang · 1×
Citations per year

Countries citing papers authored by Donna Beer–Stolz

Since Specialization
Citations

This map shows the geographic impact of Donna Beer–Stolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Beer–Stolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Beer–Stolz more than expected).

Fields of papers citing papers by Donna Beer–Stolz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Beer–Stolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Beer–Stolz. The network helps show where Donna Beer–Stolz may publish in the future.

Co-authorship network of co-authors of Donna Beer–Stolz

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Beer–Stolz. A scholar is included among the top collaborators of Donna Beer–Stolz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Beer–Stolz. Donna Beer–Stolz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 95
2 43
3 40
4 19
5 120
6 107
7 47
8 3
9 287
10 18
11 15
12 13
13 89
14 146
15 75
16 87
17 88
18 2
19 201
20 98

About Donna Beer–Stolz

Donna Beer–Stolz is a scholar working on Clinical Biochemistry, Immunology and Hepatology, having authored 28 papers that have together received 2.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Autophagy in Disease and Therapy (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Clinical Biochemistry (236 citations), Hepatology (218 citations) and Immunology (562 citations). Donna Beer–Stolz has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Andrea Sobo-Vujanovic, William Buchser, Stephan A. Munich, Nikola L. Vujanović, Simon C. Watkins, Patricia Loughran, Hai Huang, Allan Tsung, Michael T. Lotze and Evan P. Nadler. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026